Inergio 's green power units are already meeting customer needs, marking the start of exciting growth for the startup headquartered in Renens. Recently, the CEO and founder Mahmoud Hadad celebrated ...

Legacy financial institutions, such as Germany’s oldest bank, Bankhaus Metzler, and global asset manager BlackRock, are integrating solutions from Swiss fintech startups to boost efficiency. Meanwhile ...

Several Swiss start-ups have secured the necessary funds to conquer global markets.

The Mission for Essential Drugs and Supplies (MEDS) in Kenya and CHAN Medi-Pharm in Nigeria, as well as Ecumenical Pharmaceutical Network (EPN) have joined forced with Swiss startup Axmed to improve ...

With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

Swiss startup Oxyle announced a $16m funding round to scale its breakthrough solution to destroy, not just relocate, PFAS from wastewater. This builds on its $3M pre-seed round in 2022, growing ...

Zurich-based ACP Advanced Circuit Pursuit AG, recognized for its robust IP portfolio and expertise in RF CMOS technology starts a new era as part of Paris-based Sequans Communications SA, a leading ...

Major companies in the automotive, energy and agriculture sector are relying on Swiss startups to reach their CO2 emissions targets, achieve efficiency in electricity network monitoring and enable ...

Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics. By combining the safety of soft robotics with industrial ...

BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections ...

Recent startup challenges are offering new platforms for startups to showcase and advance their solutions. Elythor and Prometheus are competing for a €100,000 grand prize in the HelloTomorrow ...

AB2 Bio has entered into an option and licensing agreement with Nippon Shinyaku Co. Ltd., a leading Japanese pharmaceutical company with extensive experience in marketing rare disease therapeutics in ...